Dexamethasone Macular oedema Approved 27/07/2011 Yes implant (Ozurdex) associated with retinal vein occlusion Bortezomib Multiple Myeloma (1st Approved 27/07/2011 Yes line) Thalidomide Mulitple myeloma (1st Approved 27/07/2011 Yes line) Rituximab Follicular NHL Approved 22/06/2011 Yes (maintenance) Golimumab Rheumatoid arthritis Approved 22/06/2011 Yes (2nd line ) Naftidrofuryl oxalate Intermiittent Approved 25/05/2011 Yes claudication associated with peripheral vasular disease Romiplostim Idiopathic Approved 27/04/2011 Yes thrombocytopenia purpura Golimumab Psoriatic arthritis Approved 27/04/2011 Yes Rivastigmine Alzheimer's disease Approved 23/03/2011 Yes Rivastigmine (patch) Alzheimer's disease Approved 23/03/2011 Yes Donepezil Alzheimer's disease Approved 23/03/2011 Yes Galantamine Alzheimer's disease Approved 23/03/2011 Yes Azacitidine Myelodysplastic Approved 23/03/2011 Yes syndrome Memantine Alzheimer's disease Approved 23/03/2011 Yes Bendamustine CLL (1st line) Approved 23/02/2011 Yes Pazopanib Metastatic renal cell Ca Approved 23/02/2011 Yes (1st line) Aripiprazole (oral) Schizophrenia (15-17yo) Approved 26/01/2011 Yes Raloxifene Secondary prevention of Approved 26/01/2011 Yes osteoporosis Teriparatide Osteoporosis Approved 26/01/2011 Yes Alendronate Secondary prevention Approved 26/01/2011 Yes
Dexamethasone implant (Ozurdex) Macular oedema associated with retinal vein occlusion Approved 27/07/2011 Yes Bortezomib Multiple Myeloma (1st line) Approved 27/07/2011 Yes Thalidomide Mulitple myeloma (1st line) Approved 27/07/2011 Yes Rituximab Follicular NHL (maintenance) Approved 22/06/2011 Yes Golimumab Rheumatoid arthritis (2nd line ) Approved 22/06/2011 Yes Naftidrofuryl oxalate Intermiittent claudication associated with peripheral vasular disease Approved 25/05/2011 Yes Romiplostim Idiopathic thrombocytopenia purpura Approved 27/04/2011 Yes Golimumab Psoriatic arthritis Approved 27/04/2011 Yes Rivastigmine Alzheimer's disease Approved 23/03/2011 Yes Rivastigmine (patch) Alzheimer's disease Approved 23/03/2011 Yes Donepezil Alzheimer's disease Approved 23/03/2011 Yes Galantamine Alzheimer's disease Approved 23/03/2011 Yes Azacitidine Myelodysplastic syndrome Approved 23/03/2011 Yes Memantine Alzheimer's disease Approved 23/03/2011 Yes Bendamustine CLL (1st line) Approved 23/02/2011 Yes Pazopanib Metastatic renal cell Ca (1st line) Approved 23/02/2011 Yes Aripiprazole (oral) Schizophrenia (15-17yo) Approved 26/01/2011 Yes Raloxifene Secondary prevention of osteoporosis Approved 26/01/2011 Yes Teriparatide Osteoporosis Approved 26/01/2011 Yes Alendronate Secondary prevention Approved 26/01/2011 Yes
NICE-TA-Adherence-Check-list-September-2013-HAST.docx